These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26289409)

  • 1. Pharmacogenetic Study on the Impact of Rivastigmine Concerning Genetic Variants of A2M and IL-6 Genes on Iranian Alzheimer's Patients.
    Zamani M; Mohammadi M; Zamani H; Tavasoli A
    Mol Neurobiol; 2016 Sep; 53(7):4521-8. PubMed ID: 26289409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic and Association Studies on the Influence of HLA Alleles and Rivastigmine on the Iranian Patients with Late-Onset Alzheimer's Disease.
    Rezaei Rad F; Ghahvechi Akbari M; Zamani M; Bayat S; Zamani M
    Mol Neurobiol; 2021 Jun; 58(6):2792-2802. PubMed ID: 33502736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Response of Iranian Alzheimer's Patients to Rivastigmine Concerning Their Genotype for VDR rs11568820 and MTHFR C677T Variants: A Pharmacogenetic and Association Study.
    Rizi ZS; Shams L; Rad FR; Zamani M
    J Mol Neurosci; 2024 Aug; 74(3):75. PubMed ID: 39112893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease.
    Liao A; Nitsch RM; Greenberg SM; Finckh U; Blacker D; Albert M; Rebeck GW; Gomez-Isla T; Clatworthy A; Binetti G; Hock C; Mueller-Thomsen T; Mann U; Zuchowski K; Beisiegel U; Staehelin H; Growdon JH; Tanzi RE; Hyman BT
    Hum Mol Genet; 1998 Nov; 7(12):1953-6. PubMed ID: 9811940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha2-macroglobulin exon 24 (Val-1000-Ile) polymorphism is not associated with late-onset sporadic Alzheimer's dementia in the Hungarian population.
    Janka Z; Juhász A; Rimanóczy A; Boda K; Márki-Zay J; Palotás M; Kuk I; Zöllei M; Jakab K; Kálmán J
    Psychiatr Genet; 2002 Mar; 12(1):49-54. PubMed ID: 11901360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms.
    Zappia M; Manna I; Serra P; Cittadella R; Andreoli V; La Russa A; Annesi F; Spadafora P; Romeo N; Nicoletti G; Messina D; Gambardella A; Quattrone A
    Arch Neurol; 2004 Mar; 61(3):341-4. PubMed ID: 15023809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of alpha-2-macroglobulin deletion polymorphism with sporadic Alzheimer's disease in Koreans.
    Jhoo JH; Kim KW; Lee DY; Lee KU; Lee JH; Kim SY; Youn JY; Youn JC; Woo JI
    J Neurol Sci; 2001 Feb; 184(1):21-5. PubMed ID: 11231028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association of alpha2-macroglobulin polymorphisms with AD in southern Italy.
    Zappia M; Cittadella R; Manna I; Nicoletti G; Andreoli V; Bonavita S; Gambardella A; Quattrone A
    Neurology; 2002 Sep; 59(5):756-8. PubMed ID: 12221172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme and alpha-2-macroglobulin gene polymorphisms are not associated with Alzheimer's disease in Colombian patients.
    Camelo D; Arboleda G; Yunis JJ; Pardo R; Arango G; Solano E; López L; Hedmont D; Arboleda H
    J Neurol Sci; 2004 Mar; 218(1-2):47-51. PubMed ID: 14759632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease.
    Mariani E; Seripa D; Ingegni T; Nocentini G; Mangialasche F; Ercolani S; Cherubini A; Metastasio A; Pilotto A; Senin U; Mecocci P
    J Neurol Sci; 2006 Sep; 247(2):187-91. PubMed ID: 16784755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha2 macroglobulin and the risk of Alzheimer's disease.
    Dodel RC; Du Y; Bales KR; Gao F; Eastwood B; Glazier B; Zimmer R; Cordell B; Hake A; Evans R; Gallagher-Thompson D; Thompson LW; Tinklenberg JR; Pfefferbaum A; Sullivan EV; Yesavage J; Alstiel L; Gasser T; Farlow MR; Murphy GM; Paul SM
    Neurology; 2000 Jan; 54(2):438-42. PubMed ID: 10668709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression.
    Blennow K; Ricksten A; Prince JA; Brookes AJ; Emahazion T; Wasslavik C; Bogdanovic N; Andreasen N; Båtsman S; Marcusson J; Nägga K; Wallin A; Regland B; Olofsson H; Hesse C; Davidsson P; Minthon L; Jansson A; Palmqvist L; Rymo L
    J Neural Transm (Vienna); 2000; 107(8-9):1065-79. PubMed ID: 11041282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha2-macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease.
    Nacmias B; Tedde A; Cellini E; Forleo P; Orlacchio A; Guarnieri BM; Petruzzi C; D'Andrea F; Serio A; Sorbi S
    Neurosci Lett; 2001 Feb; 299(1-2):9-12. PubMed ID: 11166925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha2-macroglobulin polymorphism is not associated with AD or AD-type neuropathology in the Japanese.
    Sodeyama N; Yamada M; Itoh Y; Suematsu N; Matsushita M; Otomo E; Mizusawa H
    Neurology; 2000 Jan; 54(2):443-6. PubMed ID: 10668711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between haplotype -88G/25G in A2M with Alzheimer's disease.
    Song H; Jia L; Zuo X; Jia J
    Neurosci Lett; 2010 Jul; 479(2):143-5. PubMed ID: 20493925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sample.
    Crawford F; Town T; Freeman M; Schinka J; Gold M; Duara R; Mullan M
    Neurosci Lett; 1999 Aug; 270(3):133-6. PubMed ID: 10462112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic association between alpha-2 macroglobulin and Japanese sporadic Alzheimer's disease.
    Shibata N; Ohnuma T; Takahashi T; Ohtsuka E; Ueki A; Arai H
    Neurosci Lett; 1999 Aug; 271(2):132-4. PubMed ID: 10477120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association of alpha-2 macroglobulin gene five-nucleotide deletion with AD in Taiwan Chinese.
    Hu CJ; Sung SM; Liu HC; Lee KY; Hsu WC; Wong WK; Lee CC; Tsai CH; Chang JG
    Neurology; 1999 Aug; 53(3):642-3. PubMed ID: 10449138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-2 macroglobulin is genetically associated with Alzheimer disease.
    Blacker D; Wilcox MA; Laird NM; Rodes L; Horvath SM; Go RC; Perry R; Watson B; Bassett SS; McInnis MG; Albert MS; Hyman BT; Tanzi RE
    Nat Genet; 1998 Aug; 19(4):357-60. PubMed ID: 9697696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neither the tumor necrosis factor alpha-308 A/G polymorphism nor the alpha2-macroglobulin polymorphism was associated with late-onset Alzheimer's disease in the Chinese population.
    Zhang P; Yang Z; Wan CL; Zheng WD; Zhang CF; Li S; Lü ZP; Zheng CG; Jin F; Wang L
    Yi Chuan Xue Bao; 2004 Jan; 31(1):1-6. PubMed ID: 15468911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.